GL1X · GenesisL1 explorer

Research workbench

Ligand binding to farnesoid-X-receptor

Analyse Ligand binding to farnesoid-X-receptor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5Q17
Type
protein
Length
236 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bile acid receptor; Nuclear receptor coactivator peptide SRC2
UniProt
Q96RI1, A0A0B6XJZ8
Ligands
9MV
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 75% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABile acid receptorprotein22475% helix, 0% strandQ96RI1
BNuclear receptor coactivator peptide SRC2protein1258% helix, 0% strandA0A0B6XJZ8

Ligands and binding sites

  • 9MV · 4-({5-bromo-2-oxo-1'-[(thiophen-2-yl) sulfonyl]spiro[indole-3,4'-piperidin]-1(2H)-yl}methyl)benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14070.820.90469MV
21310.420.7619empty

Interfaces

1 interface between chains.

  • A–B · 553 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 5Q17 · Ligand binding to FARNESOID-X-RECEPTOR · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.